Although complicated grief (CG) following the death of a loved one has traditionally been viewed as avoidance-driven, recent research implicates approach behavior. Researchers have investigated how coping styles predict CG; however, emotional closeness remains unexamined. This study investigated the differential relationship of approach- and avoidance-focused coping on CG and depressive symptoms. Bereaved adults ( n = 340) completed questionnaires about their loss, coping styles, CG, and depression. Results suggest that approach-, but not avoidance-, focused coping mediates the relationship of emotional closeness on CG, while emotional closeness of the relationship had no direct impact on depressive symptoms. This suggests closeness of the relationship plays a unique role in CG.
The experience of emotions is a ubiquitous human experience, as is the experience of adversity. In the aftermath of an adverse life event, a variety of emotional experiences can occur. This chapter reviews the relationship between emotional responding and adversity within the science of emotion and resilience. Current literature on possible emotional responses to adversity are reviewed, including literature on both resilience and psychopathology. Multiple trajectories following the experience of various types of potentially traumatic events are outlined, including predictors for each of these trajectories. In addition, forms of psychopathology in emotional responding after adversity are discussed, including posttraumatic stress disorder, prolonged grief disorder, adjustment disorders, and other mental health conditions. Information regarding risk and resilience factors for each disorder are discussed, and evidence regarding treatment is briefly summarized.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.